Emisphere’s Stockholders Sue Over Novo Nordisk Purchase
For daily articles on the latest pharma trends and innovations, as well as interviews with leading experts and in-depth industry White Papers, subscribe to PharmaFeatures.com. A trio of lawsuits are being levelled at Emisphere Technologies over its recent sale to Novo...
3 years agoEmisphere’s Stockholders Sue Over Novo Nordisk Purchase
For daily articles on the latest pharma trends and innovations, as well as interviews with leading experts and in-depth industry White Papers, subscribe to PharmaFeatures.com. A trio of lawsuits are being levelled at Emisphere Technologies over its recent sale to Novo...
3 years ago
AstraZeneca/Alexion Purchase Held Up by CMA Amid Concerns
In December 2020, pharma giant AstraZeneca (AZ) announced its intention to acquire biopharmaceutical company Alexion. The merger would give AZ an increased portfolio in rare disease and immunology. While the US Federal Trade Commission (FTC) has approved the merger, several...
3 years agoAstraZeneca/Alexion Purchase Held Up by CMA Amid Concerns
In December 2020, pharma giant AstraZeneca (AZ) announced its intention to acquire biopharmaceutical company Alexion. The merger would give AZ an increased portfolio in rare disease and immunology. While the US Federal Trade Commission (FTC) has approved the merger, several...
3 years ago
The Current Outlook for Investment in Oncology
Oncology alone accounts for one-third of the global clinical pipeline across all therapeutic areas. In 2024, the global oncology therapeutics sales are forecasted to hit $250 billion. As the world’s largest therapeutic area, it is a highly competitive market with...
3 years agoThe Current Outlook for Investment in Oncology
Oncology alone accounts for one-third of the global clinical pipeline across all therapeutic areas. In 2024, the global oncology therapeutics sales are forecasted to hit $250 billion. As the world’s largest therapeutic area, it is a highly competitive market with...
3 years ago